We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 3,516 results
  1. Transport across Membranes: Techniques for Measuring Efflux in Fungal Cells

    One of the most prevalent mechanisms of antifungal drug resistance is export of the molecule from the fungal cells through the action of putative...
    Brooke D. Esquivel, Theodore C. White in Antifungal Drug Resistance
    Protocol 2023
  2. Luciferase-Based High-Throughput Screen with Aspergillus fumigatus to Identify Antifungal Small Molecules

    Only three classes of contemporary antifungal drugs are routinely utilized in the clinic against filamentous fungal pathogens such as Aspergillus...
    Timothy J. Opperman, Sourabh Dhingra, ... Robert A. Cramer in Antifungal Drug Resistance
    Protocol 2023
  3. Copy Number Variation and Allele Ratio Analysis in Candida albicans Using Whole Genome Sequencing Data

    Whole genome sequencing of human fungal pathogens has revolutionized the speed and accuracy in which sequence variants that cause antifungal...
    Robert T. Todd, Anna Selmecki in Antifungal Drug Resistance
    Protocol 2023
  4. A Dual-Readout High-Throughput Screening Assay for Small Molecules Active Against Aspergillus Fumigatus

    Human fungal infections caused by molds have been on the rise in recent years. These infections have high mortality rates compared to other fungal...
    Sarah R. Beattie, Damian J. Krysan in Antifungal Drug Resistance
    Protocol 2023
  5. Protocols for Measuring Tolerant and Heteroresistant Drug Responses of Pathogenic Yeasts

    The classic definition of antimicrobial susceptibility to antifungal drugs ignores the persistence of subpopulations that survive in the presence of...
    Naomi Lyons, Judith Berman in Antifungal Drug Resistance
    Protocol 2023
  6. In Silico Models for Predicting Acute Systemic Toxicity

    In this chapter, we give a brief overview of the regulatory requirements for acute systemic toxicity information in the European Union, and we review...
    Ivanka Tsakovska, Antonia Diukendjieva, Andrew P. Worth in In Silico Methods for Predicting Drug Toxicity
    Protocol 2022
  7. In Silico Models for Skin Sensitization and Irritation

    The assessment of skin irritation, and in particular of skin sensitization, has undergone an evolution process over the last years, pushing forward...
    Gianluca Selvestrel, Federica Robino, Matteo Zanotti Russo in In Silico Methods for Predicting Drug Toxicity
    Protocol 2022
  8. Using VEGAHUB Within a Weight-of-Evidence Strategy

    Industrial needs and regulatory requirements have played a significant role in accelerating the use of nontesting methods including in silico tools...
    Serena Manganelli, Alessio Gamba, ... Emilio Benfenati in In Silico Methods for Predicting Drug Toxicity
    Protocol 2022
  9. Development of In Silico Methods for Toxicity Prediction in Collaboration Between Academia and the Pharmaceutical Industry

    The pharmaceutical industry would benefit from the collaboration with academic groups in the development of predictive safety models using the newest...
    Manuel Pastor, Ferran Sanz, Frank Bringezu in In Silico Methods for Predicting Drug Toxicity
    Protocol 2022
  10. In Silico Methods for Environmental Risk Assessment: Principles, Tiered Approaches, Applications, and Future Perspectives

    This chapter aims to introduce the reader to the basic principles of environmental risk assessment of chemicals and highlights the usefulness of...
    Maria Chiara Astuto, Matteo R. Di Nicola, ... Jean-Lou C. M. Dorne in In Silico Methods for Predicting Drug Toxicity
    Protocol 2022
  11. In Silico Tools and Software to Predict ADMET of New Drug Candidates

    Implication of computational techniques and in silico tools promote not only reduction of animal experimentations but also save time and money...
    Supratik Kar, Kunal Roy, Jerzy Leszczynski in In Silico Methods for Predicting Drug Toxicity
    Protocol 2022
  12. In Silico Prediction of Chemically Induced Mutagenicity: A Weight of Evidence Approach Integrating Information from QSAR Models and Read-Across Predictions

    Information on genotoxicity is an essential piece of information in the framework of several regulations aimed at evaluating chemical toxicity. In...
    Enrico Mombelli, Giuseppa Raitano, Emilio Benfenati in In Silico Methods for Predicting Drug Toxicity
    Protocol 2022
  13. Deep Learning in Structure-Based Drug Design

    Computational methods play an increasingly important role in drug discovery. Structure-based drug design (SBDD), in particular, includes techniques...
    Protocol 2022
  14. Opportunities and Considerations in the Application of Artificial Intelligence to Pharmacokinetic Prediction

    The improvement in the ability of the pharmaceutical industry to predict human pharmacokinetic behavior are attributable to major technological...
    Protocol 2022
  15. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors

    Artificial intelligence (AI) consists of a synergistic assembly of enhanced optimization strategies with wide application in drug discovery and...
    Tânia Cova, Carla Vitorino, ... Alberto Pais in Artificial Intelligence in Drug Design
    Protocol 2022
  16. Artificial Intelligence–Enabled De Novo Design of Novel Compounds that Are Synthesizable

    Development of computer-aided de novo design methods to discover novel compounds in a speedy manner to treat human diseases has been of interest to...
    Govinda Bhisetti, Cheng Fang in Artificial Intelligence in Drug Design
    Protocol 2022
  17. Has Artificial Intelligence Impacted Drug Discovery?

    Artificial intelligence (AI) tools find increasing application in drug discovery supporting every stage of the Design-Make-Test-Analyse (DMTA) cycle....
    Atanas Patronov, Kostas Papadopoulos, Ola Engkvist in Artificial Intelligence in Drug Design
    Protocol 2022
  18. Fighting COVID-19 with Artificial Intelligence

    The development of vaccines for the treatment of COVID-19 is paving the way for new hope. Despite this, the risk of the virus mutating into a...
    Stefania Monteleone, Tahsin F. Kellici, ... Alexander Heifetz in Artificial Intelligence in Drug Design
    Protocol 2022
  19. Application of Artificial Intelligence and Machine Learning in Drug Discovery

    Machine Learning (ML) and Deep Learning (DL) are two subclasses of Artificial Intelligence (AI), that, in this day and age of big data provides...
    Protocol 2022
  20. Network-Driven Drug Discovery

    We describe an approach to early stage drug discovery that explicitly engages with the complexities of human biology. The combined computational and...
    Jonny Wray, Alan Whitmore in Artificial Intelligence in Drug Design
    Protocol 2022
Did you find what you were looking for? Share feedback.